The WHI Estrogen-Alone Trial—Do Things Look Any Better?
The findings of the Heart and Estrogen/progestin Replacement Study and Women's Health Initiative (WHI) led the FDA to recommend that estrogen preparations not be used to prevent coronary heart disease or considered first-line therapy for prevention of osteoporosis. In summary, the WHI trials su...
Gespeichert in:
| Veröffentlicht in: | JAMA : the journal of the American Medical Association 2004-04, Vol.291 (14), p.1769-1771 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1771 |
|---|---|
| container_issue | 14 |
| container_start_page | 1769 |
| container_title | JAMA : the journal of the American Medical Association |
| container_volume | 291 |
| creator | Hulley, Stephen B Grady, Deborah |
| description | The findings of the Heart and Estrogen/progestin Replacement Study and Women's Health Initiative (WHI) led the FDA to recommend that estrogen preparations not be used to prevent coronary heart disease or considered first-line therapy for prevention of osteoporosis. In summary, the WHI trials suggest that estrogen alone does not have advantages over estrogen plus progestin for treating post-menopausal women. |
| doi_str_mv | 10.1001/jama.291.14.1769 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_211310041</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><ama_id>198509</ama_id><sourcerecordid>618843121</sourcerecordid><originalsourceid>FETCH-LOGICAL-a299t-3e670dd3ab6a04932c3111d67afdb05b8c8d64976466b14169cb0be106fb63bd3</originalsourceid><addsrcrecordid>eNpFkL1OwzAUhS0EoqWww4Is9oR7Y8c_Eyql0EqVWIIYI7t2_2jj4qRDNx6CJ-RJiNQiznKG8-lc3UPINUKKAHi_MhuTZhpT5ClKoU9IF3OmEpZrdUq6AFolkiveIRd1vYJWyOQ56WAOKpOQd4kuFp6-j8Z0WDcxzH2V9Neh8rSIS7P--fp-CrRYLKt5TSchfNB-taePvml8fLgkZzOzrv3V0Xvk7XlYDEbJ5PVlPOhPEpNp3STMCwnOMWOFAa5ZNmWI6IQ0M2cht2qqnOBaCi6ERY5CTy1YjyBmVjDrWI_cHXq3MXzufN2Uq7CLVXuyzBBZuwPHFro9Qju78a7cxuXGxH3592gL3ByAdrH_VKscNPsF9ANbtQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>211310041</pqid></control><display><type>article</type><title>The WHI Estrogen-Alone Trial—Do Things Look Any Better?</title><source>MEDLINE</source><source>American Medical Association Journals</source><creator>Hulley, Stephen B ; Grady, Deborah</creator><creatorcontrib>Hulley, Stephen B ; Grady, Deborah</creatorcontrib><description>The findings of the Heart and Estrogen/progestin Replacement Study and Women's Health Initiative (WHI) led the FDA to recommend that estrogen preparations not be used to prevent coronary heart disease or considered first-line therapy for prevention of osteoporosis. In summary, the WHI trials suggest that estrogen alone does not have advantages over estrogen plus progestin for treating post-menopausal women.</description><identifier>ISSN: 0098-7484</identifier><identifier>EISSN: 1538-3598</identifier><identifier>DOI: 10.1001/jama.291.14.1769</identifier><identifier>PMID: 15082705</identifier><identifier>CODEN: JAMAAP</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Clinical trials ; Coronary Disease - epidemiology ; Coronary Disease - prevention & control ; Estrogen Replacement Therapy - adverse effects ; Estrogens ; Estrogens - adverse effects ; Estrogens - therapeutic use ; Estrogens, Conjugated (USP) - adverse effects ; Estrogens, Conjugated (USP) - therapeutic use ; Female ; Hormone replacement therapy ; Humans ; Menopause ; Postmenopause ; Risk Assessment</subject><ispartof>JAMA : the journal of the American Medical Association, 2004-04, Vol.291 (14), p.1769-1771</ispartof><rights>Copyright American Medical Association Apr 14, 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a299t-3e670dd3ab6a04932c3111d67afdb05b8c8d64976466b14169cb0be106fb63bd3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://jamanetwork.com/journals/jama/articlepdf/10.1001/jama.291.14.1769$$EPDF$$P50$$Gama$$H</linktopdf><linktohtml>$$Uhttps://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.291.14.1769$$EHTML$$P50$$Gama$$H</linktohtml><link.rule.ids>64,314,780,784,3338,27923,27924,76260,76263</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15082705$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hulley, Stephen B</creatorcontrib><creatorcontrib>Grady, Deborah</creatorcontrib><title>The WHI Estrogen-Alone Trial—Do Things Look Any Better?</title><title>JAMA : the journal of the American Medical Association</title><addtitle>JAMA</addtitle><description>The findings of the Heart and Estrogen/progestin Replacement Study and Women's Health Initiative (WHI) led the FDA to recommend that estrogen preparations not be used to prevent coronary heart disease or considered first-line therapy for prevention of osteoporosis. In summary, the WHI trials suggest that estrogen alone does not have advantages over estrogen plus progestin for treating post-menopausal women.</description><subject>Clinical trials</subject><subject>Coronary Disease - epidemiology</subject><subject>Coronary Disease - prevention & control</subject><subject>Estrogen Replacement Therapy - adverse effects</subject><subject>Estrogens</subject><subject>Estrogens - adverse effects</subject><subject>Estrogens - therapeutic use</subject><subject>Estrogens, Conjugated (USP) - adverse effects</subject><subject>Estrogens, Conjugated (USP) - therapeutic use</subject><subject>Female</subject><subject>Hormone replacement therapy</subject><subject>Humans</subject><subject>Menopause</subject><subject>Postmenopause</subject><subject>Risk Assessment</subject><issn>0098-7484</issn><issn>1538-3598</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkL1OwzAUhS0EoqWww4Is9oR7Y8c_Eyql0EqVWIIYI7t2_2jj4qRDNx6CJ-RJiNQiznKG8-lc3UPINUKKAHi_MhuTZhpT5ClKoU9IF3OmEpZrdUq6AFolkiveIRd1vYJWyOQ56WAOKpOQd4kuFp6-j8Z0WDcxzH2V9Neh8rSIS7P--fp-CrRYLKt5TSchfNB-taePvml8fLgkZzOzrv3V0Xvk7XlYDEbJ5PVlPOhPEpNp3STMCwnOMWOFAa5ZNmWI6IQ0M2cht2qqnOBaCi6ERY5CTy1YjyBmVjDrWI_cHXq3MXzufN2Uq7CLVXuyzBBZuwPHFro9Qju78a7cxuXGxH3592gL3ByAdrH_VKscNPsF9ANbtQ</recordid><startdate>20040414</startdate><enddate>20040414</enddate><creator>Hulley, Stephen B</creator><creator>Grady, Deborah</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QL</scope><scope>7QP</scope><scope>7TK</scope><scope>7TS</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20040414</creationdate><title>The WHI Estrogen-Alone Trial—Do Things Look Any Better?</title><author>Hulley, Stephen B ; Grady, Deborah</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a299t-3e670dd3ab6a04932c3111d67afdb05b8c8d64976466b14169cb0be106fb63bd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Clinical trials</topic><topic>Coronary Disease - epidemiology</topic><topic>Coronary Disease - prevention & control</topic><topic>Estrogen Replacement Therapy - adverse effects</topic><topic>Estrogens</topic><topic>Estrogens - adverse effects</topic><topic>Estrogens - therapeutic use</topic><topic>Estrogens, Conjugated (USP) - adverse effects</topic><topic>Estrogens, Conjugated (USP) - therapeutic use</topic><topic>Female</topic><topic>Hormone replacement therapy</topic><topic>Humans</topic><topic>Menopause</topic><topic>Postmenopause</topic><topic>Risk Assessment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hulley, Stephen B</creatorcontrib><creatorcontrib>Grady, Deborah</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>JAMA : the journal of the American Medical Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hulley, Stephen B</au><au>Grady, Deborah</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The WHI Estrogen-Alone Trial—Do Things Look Any Better?</atitle><jtitle>JAMA : the journal of the American Medical Association</jtitle><addtitle>JAMA</addtitle><date>2004-04-14</date><risdate>2004</risdate><volume>291</volume><issue>14</issue><spage>1769</spage><epage>1771</epage><pages>1769-1771</pages><issn>0098-7484</issn><eissn>1538-3598</eissn><coden>JAMAAP</coden><abstract>The findings of the Heart and Estrogen/progestin Replacement Study and Women's Health Initiative (WHI) led the FDA to recommend that estrogen preparations not be used to prevent coronary heart disease or considered first-line therapy for prevention of osteoporosis. In summary, the WHI trials suggest that estrogen alone does not have advantages over estrogen plus progestin for treating post-menopausal women.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>15082705</pmid><doi>10.1001/jama.291.14.1769</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0098-7484 |
| ispartof | JAMA : the journal of the American Medical Association, 2004-04, Vol.291 (14), p.1769-1771 |
| issn | 0098-7484 1538-3598 |
| language | eng |
| recordid | cdi_proquest_journals_211310041 |
| source | MEDLINE; American Medical Association Journals |
| subjects | Clinical trials Coronary Disease - epidemiology Coronary Disease - prevention & control Estrogen Replacement Therapy - adverse effects Estrogens Estrogens - adverse effects Estrogens - therapeutic use Estrogens, Conjugated (USP) - adverse effects Estrogens, Conjugated (USP) - therapeutic use Female Hormone replacement therapy Humans Menopause Postmenopause Risk Assessment |
| title | The WHI Estrogen-Alone Trial—Do Things Look Any Better? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T17%3A08%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20WHI%20Estrogen-Alone%20Trial%E2%80%94Do%20Things%20Look%20Any%20Better?&rft.jtitle=JAMA%20:%20the%20journal%20of%20the%20American%20Medical%20Association&rft.au=Hulley,%20Stephen%20B&rft.date=2004-04-14&rft.volume=291&rft.issue=14&rft.spage=1769&rft.epage=1771&rft.pages=1769-1771&rft.issn=0098-7484&rft.eissn=1538-3598&rft.coden=JAMAAP&rft_id=info:doi/10.1001/jama.291.14.1769&rft_dat=%3Cproquest_pubme%3E618843121%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=211310041&rft_id=info:pmid/15082705&rft_ama_id=198509&rfr_iscdi=true |